|
|
TIL products generated from bone marrow metastases for neuroblastoma patients as potential |
Speaker:
Suzanne Castenmiller |
23 January |
10:45
11:00
|
SC Papendal
Room 4/5
|
|
|
|
Targeting tumor metabolism using affinity enhanced engineered T cells and bispecifics |
Speaker:
Mara Nicolasen |
23 January |
11:00
11:15
|
SC Papendal
Room 4/5
|
|
|
|
T cell engineering |
Speaker:
Brenda Raud |
23 January |
11:15
11:30
|
SC Papendal
Room 4/5
|
|
|
|
Relevance of CCR5 in the efficacy of αβT cell based immunotherapies |
Speaker:
Caroline Schwenzel |
23 January |
11:30
11:45
|
SC Papendal
Room 4/5
|
|
|
|
T cell receptor gene therapy targeting mutant NPM1 on acute myeloid leukemia |
Speaker:
Eva Argiro |
23 January |
11:45
12:00
|
SC Papendal
Room 4/5
|
|
|
|
Dual role of heme oxygenase-1 in mice and men with acute graft-versus-host disease |
Speaker:
Myrddin Verheij |
23 January |
12:00
12:15
|
SC Papendal
Room 4/5
|
|
